Ligand design for α1 adrenoceptor subtype selective antagonists

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 1, 2000, Pages 201-214

  Bremner, John B ^a   Coban, Burak ^a   Griffith, Renate ^a   Groenewoud, Karina M ^b   Yates, Brian F ^b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Adrenergic receptors; Aporphine analogues; Drug design; Selectivity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; LIGAND;

ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; DRUG DESIGN; DRUG STRUCTURE; ELECTRICITY; RECEPTOR BINDING; ANIMAL; CELL STRAIN COS1; CHEMICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; HUMAN; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; COS CELLS; ELECTROSTATICS; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MODELS, CHEMICAL; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0033624218     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00263-1     Document Type: Article

References (42)

1. Beck-Sickinger A. Drug Discovery Today. 1:1996;502.
2. Graham R.M., Perez D.M., Piasciks M.T., Riek R.P., Hwa J. Pharmacol. Commun. 6:1995;15.
3. Hieble J.P., Bondinell W.E., Ruffolo R.R. Jr. J. Med. Chem. 38:1995;1838.
4. Ruffolo R.R. Jr., Bondinell W., Hieble J.P. J. Med. Chem. 38:1995;3681.
5. Alexander, S. P. H.; Peters, J. A. Eds., The 1998-receptor and ion channel nomenclature supplement, In: Trend. Pharmacol. Sci. 9th, Elsevier Trends Journals: Cambridge, 1998.
6. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R. Jr. Trendelenburg, U. Pharmacol. Rev. 46:1994;121.
7. Forray C., Wetzel J.M., Branchek T.A., Bard J.A., Chiu G., Shapiro E., Tang R., Lepor H., Hartig P.R., Weinshank R.L., Gluchowski C. Mol. Pharmacol. 45:1994;703.
8. Gluchowski, C.; Wetzel, J. M.; Chiu, G.; Marzabadi, M. R.; Wong, W. C.; Nagarathnam, D. International Patent No. WO 94/22829, 1994.
9. Konkel, M. J.; Wetzel, J. M.; Cahir, M.; Craig, D.; Noble, S. A.; Gluchowski, C. The 216th ACS National Meeting, Boston, 23-27 August, 1998, MEDI#129.
10. Meyer M.D., Altenbach R.J., Basha F.Z., Carroll W.A., Drizin I., Elmore S.W., Ehrlich P.P., Lebold S.A., Tietje K., Sippy K.B., Wendt M.D., Plata D.J., Plagge F., Buckner S.A., Brune M.E., Hancock A.A., Kerwin J.F. Jr. J. Med. Chem. 40:1997;3141.
11. Giardina D., Crucianelli M., Melchiorre C., Taddei C., Testa R. Eur. J. Pharmacol. 287:1995;13.
12. Testa R., Guarnery L., Angelico P., Poggesi E., Taddei C., Sironi G., Colombo D., Sulpizio A.C., Naselsky D.P., Hieble J.B., Leonardi A. J. Pharmacol. Exp. Ther. 281:1997;1284.
13. Kenny B., Ballard S., Blagg J., Fox D. J. Med. Chem. 40:1997;1293.
14. 1-adrenoceptors. IBC-GPCR Conference, Philadelphia, PA, 11-13 December 1995.
15. Foglar R., Shibata K., Horie K., Hirasawa A., Tsujimuto G. Eur. J. Pharmacol. 288:1995;201.
16. King H.K., Goetz A.S., Ward S.D.C., Saussy D.L. Jr. Soc. Neuro. Abs. 20:1994;526.
17. DeBenedetti P.G., Fanelli F., Menziani M.C., Cocchi M., Testa R., Leonardi A. Bioorg. Med. Chem. 5:1997;809.
18. Ko F.N., Guh J.H., Yu S.M., Hou Y.S., Wu Y.C., Teng C.M. Br. J. Pharmacol. 112:1994;1174.
19. Ford A.P.D.W., Williams T.J., Blue D.R., Clarke D.E. Trend. Pharmacol. Sci. 15:1994;167.
20. Phife D.W., Ramos R.A., Feng M., King I., Gunasekera S.P., Wright A., Patel M., Pachter J.A., Coval S.J. Bioorg. Med. Chem. Lett. 6:1996;2103.
21. De Marinis, R. M.; Wise, M.; Hieble, J. P; Ruffolo, Jr., R. R. In The alpha-1 Adrenergic Receptor; Ruffolo, Jr., R. R. Ed.; Humana Press: New Jersey, 1987; pp. 211-258.
22. DeBenedetti P.G., Fanelli F., Menziani M.C., Cocchi M. J. Mol. Struc. 305:1995;101.
23. Cocchi M., Fanelli F., Menziani M.C., DeBenedetti P.G. J. Mol. Struc. 331:1995;79.
24. Venturelli M., Menziani M.C., Cocchi M., Fanelli F., DeBenedetti P.G. (Theochem)-Journal of Molecular Structure. 276:1992;327.
25. Bremner J.B., Coban B., Griffith R. J. Comp. Aid. Mol. Des. 10:1996;545.
26. Shamma M. The Isoquinoline Alkaloids. 1972;Chemistry and Pharmacology Academic Press Inc, New York.
27. Madrero Y., Elorriaga M., Martinez S., Noguera M.A., Cassels B.K., D'Ocon P., Ivorra M.D. Brit. J. Pharmacol. 119:1996;1563.
28. Groenewoud, K. M. Ring-D Aporphine Analogues. B.Sc. honours thesis, Department of Chemistry, University of Tasmania, 1991.
29. Sleight A.J., Koek W., Bigg D.C.H. Eur. J. Pharmacol. 238:1993;407.
30. Wetzel J.M., Salon S.A., Tamm J.A., Forray C., Craig D., Nakanishi H., Cui W., Vaysse P.J.J., Chiu G., Weinshank R.L., Hartig P.R., Branchek T.A., Gluchowski C. Receptors and Channels. 4:1996;165.
31. Hamaguchi N., True T.A., Saussy D.L., Jeffs P.W. Biochemistry. 35:1996;14313.
32. Brossi A., Dolan L.A., Teitel S. Org. Synth. 56:1977;3.
33. Berney D. Helv. Chim. Acta. 65:1982;1694.
34. Bremner J.B., Browne E.J. J. Heterocyc. Chem. 12:1975;301.
35. Greene J., Kahn S., Savoj H., Sprague P., Teig S. J. Chem. Inf. Comp. Sci. 34:1994;1297.
36. Brooks B.R., Brucolleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. J. Comput. Chem. 4:1983;187.
37. Smellie A., Kahn S.D., Teig S.L. J. Chem. Inf. Comp. Sci. 35:1995;285.
38. Smellie A., Kahn S.D., Teig S.L. J. Chem. Inf. Comp. Sci. 35:1995;295.
39. Griffith, R.; Bremner, J. B.; Coban, B. In Pharmacophore Perception, Development, and Use in Drug Design; Guner, O., Ed.; International University Line: La Jolla, in press.
40. Perrin D.D., Armarego W.L.F. Purification of Laboratory Chemicals. 3rd Ed. 1988;Pergamon Press, Oxford.
41. Perez D.M., Piascik M.T., Graham R.M. Mol. Pharmacol. 40:1991;876.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual:1989;Cold Spring Harbor Laboratory, Cold Spring Harbour, New York.